Striverdi Respimat is indicated as a maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
Rapid Review
| Commenced | Completed | Outcome |
| 07/04/2014 | 02/05/2014 | Full Pharmacoeconomic Evaluation Not Recommended |
Striverdi Respimat is indicated as a maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
Rapid Review
| Commenced | Completed | Outcome |
| 07/04/2014 | 02/05/2014 | Full Pharmacoeconomic Evaluation Not Recommended |